Enovis

Enovis Interest Coverage

The Interest Coverage Ratio of Enovis (ENOV) as of Oct 16, 2026 is -13.41. In the previous year, Interest Coverage Ratio was -2.40 — a change of 459.05% (lower).

Interest Coverage

-13.41

YoY

459.05%

Last updated:

Interest Coverage Ratio of Enovis is 2024 -13.41 . Interest Coverage Ratio of Enovis was 2023 -2.40 . It decreases by 459.05% lower compared to the previous year.

The Enovis Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
0.73 USD
Jan 1, 2018
4.83 USD
Jan 1, 2019
1.42 USD
Jan 1, 2020
1.52 USD
Jan 1, 2021
-2.16 USD
Jan 1, 2022
-0.81 USD
Jan 1, 2023
-2.40 USD
Jan 1, 2024
-13.41 USD
The Enovis Interest Coverage history
YEARInterest CoverageYoY
-13.41+459.05%
-2.40+194.64%
-0.81-62.25%
-2.16-241.77%
1.52+6.96%
1.42-70.55%
4.83+564.60%
0.73-90.75%
7.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enovis Stock analysis

What does Enovis do? Enovis Corp, listed on the stock market with ticker ENOV and ISIN US1940145022, is a health care company headquartered in Wilmington, United States. The company has 7,802 employees and went public on May 8, 2008. Enovis operates within the health care sector, focusing on medical technology and the development of clinically differentiated solutions. The company manufactures and distributes medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. It functions through two operational segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment offers products including rigid bracing, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy solutions, alongside recovery sciences products such as bone growth stimulators and electrical stimulators for clinical rehabilitation and sports medicine. The Reconstructive segment specializes in knee, hip, shoulder, elbow, foot, ankle, and finger implant products, as well as surgical productivity solutions. Additionally, Enovis provides Novastep, a minimally invasive surgery solution for foot and ankle procedures. The company's website is www.enovis.com. Enovis Corp is engaged in the production and distribution of medical devices aimed at improving patient outcomes through innovative technology and solutions in the health care industry. Enovis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enovis stock

Interest Coverage Ratio of Enovis is -13.41 in 2024.

Interest Coverage Ratio of Enovis changed from -2.40 to -13.41, representing a 459.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Enovis since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Enovis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Enovis

All Key Metrics — Enovis